Dongin (Donoven) Kim, Ph.D.

---

Publications & Presentations

41. Ragheb R R, Kim D, Bandyopadhyay A, Chahboune H, Bulutoglu B, Ezaldein H, Criscione J M, Fahmy T M. Induced clustered nanoconfinement of superparamagnetic iron oxide in biodegradable nanoparticles enhances transverse relaxivity for targeted theranostics. Magnetic resonance in medicine. 2013; 70 : 1748-60

42. Dasari M, Acharya A P, Kim D, Lee S, Lee S, Rhea J, Molinaro R, Murthy N. H-gemcitabine: a new gemcitabine prodrug for treating cancer. Bioconjugate chemistry. 2013; 24 : 4-8

43. Park W, Kim D, Kang H C, Bae Y H, Na K. Multi-arm histidine copolymer for controlled release of insulin from poly(lactide-co-glycolide) microsphere. Biomaterials. 2012; 33 : 8848-57

44. Ning X, Lee S, Wang Z, Kim D, Stubblefield B, Gilbert E, Murthy N. Maltodextrin-based imaging probes detect bacteria in vivo with high sensitivity and specificity. Nature materials. 2011; 10 : 602-7

45. Kim I, Kim T H, Ma K, Lee E S, Kim D, Oh K T, Lee D H, Lee K C, Youn Y S. Synthesis and evaluation of human serum albumin-modified exendin-4 conjugate via heterobifunctional polyethylene glycol linkage with protracted hypoglycemic efficacy. Bioconjugate chemistry. 2010; 21 : 1513-9

Grants

11. Exosome based intraocular therapy combined with active targeting of ocular neovascularization. NIH. Start Date: 2022. End Date: 2022.

12. Translational Studies on Extracellular Vesicles in Ovarian Cancer. Non-federal. Start Date: 2022. End Date: 2022.

13. Developing RNAi-based control method targeting Mormon cricket. Misc Federal. Start Date: 2020. End Date: 2021.

Awards and Honors

no results

Education

1. Degree: Ph D. University of Utah. Date: 2009.


2. Degree: MS. University of Florida. Date: 2002.


3. Degree: BS. Ajou University. Date: 1999.

Administrative Assignments

no results